• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Wei-Li Chen, Chung-Tien Lin, Chia-Yun Hsieh, I-Hua Tu, Willie Y.W Chen, Fung-Rong Hu
  • Medicine
  • Cornea
  • 2007 (First Publication: 1 December 2007)
  • PURPOSE To compare the bacteriostatic effects, corneal cytotoxicity, and ability to seal corneal incisions among fibrin glue and 2 commercially available cyanoacrylate derivatives: N-butylContinue Reading
  • Wei-Li Chen, Chung-Tien Lin, +5 authors Fung-Rong Hu
  • Medicine
  • Investigative ophthalmology & visual science
  • 2009 (First Publication: 1 April 2009)
  • PURPOSE Bevacizumab is a potent recombinant humanized monoclonal antibody directed against vascular endothelial growth factor (VEGF). The purpose of this study was to evaluate the therapeutic effectContinue Reading
  • Chien-Fan Fong, Fung-Rong Hu, C L Tseng, I Wang, Wei-Li Chen, Yu-Chih Hou
  • Medicine
  • American journal of ophthalmology
  • 2007 (First Publication: 1 November 2007)
  • PURPOSE To analyze in vitro antibiotic susceptibility of bacterial isolates from patients with bacterial keratitis at the National Taiwan University Hospital over the past 12 years. DESIGNContinue Reading
  • Pei-Yao Chang, Hyman Carrel, +5 authors Fung-Rong Hu
  • Medicine
  • American journal of ophthalmology
  • 2006 (First Publication: 1 September 2006)
  • PURPOSE To define alterations in the density of corneal basal epithelium in relation to diabetic retinopathic severity and the alteration of corneal innervation using confocal microscopy. DESIGNContinue Reading
  • Chung-Tien Lin, Fung-Rong Hu, +4 authors Wei-Li Chen
  • Medicine
  • Investigative ophthalmology & visual science
  • 2010 (First Publication: 1 December 2010)
  • PURPOSE To compare the effects of early, mid, and late subconjunctival injection of bevacizumab on corneal neovascularization (NV) and conjunctivalization in a rabbit limbal insufficiency model. Continue Reading